KARBE FRANK 4
4 · Phathom Pharmaceuticals, Inc. · Filed May 31, 2024
Insider Transaction Report
Form 4
KARBE FRANK
Director
Transactions
- Award
Common Stock
2024-05-29$10.16/sh+25,000$254,113→ 44,500 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.1016 to $10.20. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.